Skip to main content
OpenTrials

Clinical trial condition

Recurrent Hypopharyngeal Squamous Cell Carcinoma

Explore clinical trials studying Recurrent Hypopharyngeal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

20 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Hypopharyngeal Squamous Cell Carcinoma trial results

Completed

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

NCT01256385

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 24 locations
View Trial Details
Completed

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

NCT02007200

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +42 more
Locations
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

NCT05063552

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Epic Care-Dublin Dublin, California, United States
  • Epic Care Partners in Cancer Care Emeryville, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 781 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

NCT05172258

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions